|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Copenhagen, Denmark
2 University of Copenhagen
3 Department of Biology, August Krogh Building
* To whom correspondence should be addressed. E-mail: sfpedersen{at}aki.ku.dk.
The Ca2+-independent phospholipase A2 group VI (PLA2-VI) and the Na+/H+ exchanger isoform 1 (NHE1) are highly pH sensitive proteins which exert both protective and detrimental effects in cardiac ischemia/reperfusion. Here, we investigated the role of pHo in ischemia/reperfusion injury and death, and in regulation and function of iPLA2-VI and NHE1 under these conditions. HL-1 cardiomyocytes were exposed to simulated ischemia (SI, 0.5% O2, 8 mM K+, 20 mM lactate) at pHo 6.0 and 7.4, with or without 4 or 8 h of reperfusion (SI/R). Cytochrome c release and caspase-3 activation were reduced after acidic compared to neutral SI, while necrotic death, estimated as glucose-6-phosphate dehydrogenase release, was similar in the two conditions. Inhibition of iPLA2-VI activity by bromoenol lactone (BEL) elicited cardiomyocyte necrosis during normoxia and after acidic, yet not after neutral SI. The isoform-selective enantiomers R- and S-BEL both mimicked the effect of racemic BEL after acidic SI. In contrast, inhibition of NHE activity by 5'N-ethylisopropylamiloride (EIPA) had no significant effect on necrosis after SI. Both neutral and acidic SI were associated with a reversible loss of F-actin and cortactin integrity. Inhibition of iPLA2-VI disrupted F-actin, cortactin, and mitochondrial integrity, while inhibition of NHE slightly reduced stress fibre content. iPLA2-VIA and NHE1 mRNA levels were reduced during SI and upregulated in a pHo dependent manner during SI/R, which also affected the subcellular localization of both proteins. Thus, the mode of cell death, and the roles and regulation of iPLA2-VI and NHE1, are at least in part determined by the pHo during SI. In addition to having clinically relevant implications, these finding can in part explain the contradictory results obtained from previous studies of iPLA2-VIA and NHE1 during cardiac ischemia/reperfusion.
This article has been cited by other articles:
![]() |
B.-Y. Kang and J. L. Mehta Rosuvastatin Attenuates Ang II--Mediated Cardiomyocyte Hypertrophy via Inhibition of LOX-1 Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 283 - 291. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |